VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - TSX:VHI - CA92847V5018 - Common Stock
8.85 CAD
-0.3 (-3.28%)
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes VHI very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
VHI had positive earnings in the past year.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
VHI has a better Return On Assets (0.76%) than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 1.08%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 2.86%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 2.88%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a Operating Margin of 12.47%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
VHI's Gross Margin of 80.92% is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
The number of shares outstanding for VHI has been increased compared to 5 years ago.
VHI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.84 indicates that VHI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.84, VHI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
The Debt to FCF ratio of VHI is 0.13, which is an excellent value as it means it would take VHI, only 0.13 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.13, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI has a better Debt to Equity ratio (0.00) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.84 |
ROIC/WACC0.29
WACC9.78%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI has a better Current ratio (1.94) than 87.50% of its industry peers.
A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.94, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -36.36% in the last year.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 59.34%.
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.4%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 82.03% yearly.
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.30% yearly.
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
VHI is valuated quite expensively with a Price/Earnings ratio of 126.43.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of VHI to the average of the S&P500 Index (25.56), we can say VHI is valued expensively.
With a Price/Forward Earnings ratio of 29.40, VHI can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, VHI is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.62. VHI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 126.43 | ||
| Fwd PE | 29.4 |
4.2 Price Multiples
VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.76 | ||
| EV/EBITDA | 20.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VHI does not grow enough to justify the current Price/Earnings ratio.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.85
PEG (5Y)N/A
EPS Next 2Y107.36%
EPS Next 3Y82.03%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (11/17/2025, 7:00:00 PM)
8.85
-0.3 (-3.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap557.55M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.74 (77.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-0.28%
PT rev (3m)5.02%
EPS NQ rev (1m)-7.64%
EPS NQ rev (3m)-10.93%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-46.62%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)5.06%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)4.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 126.43 | ||
| Fwd PE | 29.4 | ||
| P/S | 5.68 | ||
| P/FCF | 45.76 | ||
| P/OCF | 43.16 | ||
| P/B | 2.13 | ||
| P/tB | 11.32 | ||
| EV/EBITDA | 20.81 |
EPS(TTM)0.07
EY0.79%
EPS(NY)0.3
Fwd EY3.4%
FCF(TTM)0.19
FCFY2.19%
OCF(TTM)0.21
OCFY2.32%
SpS1.56
BVpS4.16
TBVpS0.78
PEG (NY)1.85
PEG (5Y)N/A
Graham Number2.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.84 |
F-Score3
WACC9.78%
ROIC/WACC0.29
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.4%
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 126.43 and the Price/Book (PB) ratio is 2.13.